eClinical Tech News

Agomab Therapeutics has extended its cash runway into the first half of 2029 after raising $208 million in gross...

Clinuvel has secured final scientific advice from the European Medicines Agency on its pivotal Phase III CUV107 trial evaluating...

WHO has prequalified Coartem (artemether-lumefantrine) Baby, a new formulation designed for newborns and young infants weighing 2 to 5...

Ipsen posted first‑quarter 2026 sales of €1.07 billion, up 17% as reported and 22.6% at constant exchange rates, and...

TG Therapeutics used the AAN 2026 stage to advance the positioning of BRIUMVI in relapsing multiple sclerosis, presenting new...

Capricor Therapeutics presented Phase 3 HOPE-3 data for Deramiocel (CAP-1002) in Duchenne muscular dystrophy at the American Academy of...

FDA has approved Dupixent (dupilumab) for children aged two to 11 with chronic spontaneous urticaria (CSU) who remain symptomatic...

Humacyte’s bid to globalize its bioengineered vascular graft moved a step forward as Israel’s Ministry of Health accepted the...

Telix Pharmaceuticals will deliver late-breaking Part 1 data from its global Phase 3 ProstACT study of TLX591-Tx, a PSMA-targeted...

Rezolute will deliver an oral presentation of Phase 3 results for ersodetug (sunRIZE; RZ358-301) in congenital hyperinsulinism at the...